Global Viral Clearance Market

Viral Clearance Market by Applications (Cellular & Gene Therapy Products, Blood & Blood Products, Vaccines & Therapeutics, Tissue & Tissue Products, and Stem Cell Products), Methods (Viral Inactivation Method, Viral Detection Method, and Viral Removal Method), End-users (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2455
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 177
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global viral clearance market size is projected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising government funding for the pharmaceutical and biotechnology industries.


Global Viral Clearance Market summary

Viruses are types of organisms that are responsible for various infectious diseases that can reproduce rapidly inside the living cells of human beings. Viruses generally infect all types of life forms including animals and plants. Viruses have the ability to multiply on their own and can infect animal or human cell. They also have the ability to infect bacterial cells by damaging the cell and bringing out their multiplication and growth in the host cell. The infected cell produces viral particles rather than their regular products.

The analysis of the capability to produce a risk-free product and ensure the safety of the product for human use is a vital aspect of viral clearance method. Several technical calculation are deployed to gauge the level of the products safety by controlling the presence or infection by virus during the manufacturing of the product. To achieve this agenda, there is a requirement to eventually conduct viral clearance and implementation of viral safety assessment in the course of product evolution. Viral infections affect bioreactor contamination, raw materials, downstream processing, and cell culture processes. This is expected to help in forming the demand for viral safety practice and the implementation of the virus clearance process.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising demand for the safety of a product and the development of innovative techniques that can enhance the capability of a mechanical process to determine accurate viral clearance present a key factor boosting the market growth.
  • Presence of a strong product pipeline and the growing development of the pharmaceutical industry are expected to fuel the market growth.
  • Rising government funding for the biotechnology industry and rising R&D activities to develop innovative novel drugs are expected to fuel the market expansion.
  • Increasing strict government regulations emphasizing on quality control and quality assurance of various industrial products are projected to boost the growth of the global market.
  • High degree of consolidation act is one of the major restraining factors expected to hamper the global viral clearance market.

Scope of the Report                          

The report on the global viral clearance market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Viral Clearance Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Cellular & Gene Therapy Products, Blood & Blood Products, Vaccines & Therapeutics, Tissue & Tissue Products, and Stem Cell Products), Methods (Viral Inactivation Method, Viral Detection Method, and Viral Removal Method), End-users (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Lonza Group; Charles River Laboratories International, Inc.; Sigma-Aldrich Corporation; Merck KGaA; Avance Biosciences Inc.; Clean Cells; BSL Bioservice Scientific Laboratories GmbH; SGS S.A.; Texcell, Inc.; and WuXi PharmaTech Inc.

Market Segment Insights

Vaccines & therapeutics segment is expected to account for a key share

Based on applications, the global viral clearance market is divided into cellular & gene therapy products, blood & blood products, vaccines & therapeutics, tissue & tissue products, and stem cell products. The vaccines & therapeutics segment is expected to account for a key share of the market during the projected period due to advance wide development of new vaccines and implementation of advanced therapeutic procedures introduced in the market. However, the cellular & gene therapy products segment is anticipated to expand at a rapid pace during the forecast period owing to various awareness campaigns by market players and healthcare authorities.


Global Viral Clearance Market application

Viral inactivation method segment is projected to expand at a considerable CAGR

On the basis of methods, the market is segmented into viral inactivation method, viral detection method, and viral removal method. The viral inactivation method segment is projected to expand at a considerable CAGR during the forecast period owing to various R&D activities to enhance the procedure. On the other hand, the viral removal method segment is anticipated to expand at an impressive growth rate during the forecast period due to technology advancement in the field.


Global Viral Clearance Market methods

Contract research organizations segment is expected to exhibit robust growth

In terms of end-users, the global viral clearance market is classified into contract research organizations, pharmaceutical & biotechnology companies, academic research institutes, and other. The contract research organizations segment is expected to exhibit robust growth of the market in the coming years owing to increasing investments by key market players towards several research organizations to enhance their products. Meanwhile, the academic research institutes segment is anticipated to expand at a healthy growth rate during the forecast period due to supportive government policies towards academic institutions.


Global Viral Clearance Market end-users

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America accounted for a key share of the market in 2019 and is anticipated to constitute a key market share during the targeted period due to rising awareness and increasing investments by healthcare authorities towards viral clinical research in the region. The market of Asia Pacific, however, is anticipated to expand at a rapid pace during the forecast period owing to increasing healthcare expenditure and developing healthcare infrastructure in the region.


Global Viral Clearance Market region

Segments

Segments Covered in the Report
The global viral clearance market has been segmented on the basis of
Applications

  • Cellular & Gene Therapy Products
  • Blood & Blood Products
  • Vaccines & Therapeutics
  • Tissue & Tissue Products
  • Stem Cell Products

Methods

  • Viral Inactivation Method
  • Viral Detection Method
  • Viral Removal Method

End-users

  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

 

Competitive Landscape

Key players competing in the global viral clearance market are Lonza Group; Charles River Laboratories International, Inc.; Sigma-Aldrich Corporation; Merck KGaA; Avance Biosciences Inc.; Clean Cells; BSL Bioservice Scientific Laboratories GmbH; SGS S.A.; Texcell, Inc.; and Wuxi PharmaTech Inc. The main market players are continuously looking for several market development activities and opportunities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations to enhance their market positions.

Global Viral Clearance Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Viral Clearance Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Viral Clearance Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Viral Clearance Market - Supply Chain
  4.5. Global Viral Clearance Market Forecast
     4.5.1. Viral Clearance Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Viral Clearance Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Viral Clearance Market Absolute $ Opportunity
5. Global Viral Clearance Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Viral Clearance Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Viral Clearance Demand Share Forecast, 2019-2026
6. North America Viral Clearance Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Viral Clearance Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Viral Clearance Demand Share Forecast, 2019-2026
7. Latin America Viral Clearance Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Viral Clearance Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Viral Clearance Demand Share Forecast, 2019-2026
8. Europe Viral Clearance Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Viral Clearance Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Viral Clearance Demand Share Forecast, 2019-2026
9. Asia Pacific Viral Clearance Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Viral Clearance Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Viral Clearance Demand Share Forecast, 2019-2026
10. Middle East & Africa Viral Clearance Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Viral Clearance Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Viral Clearance Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Viral Clearance Market: Market Share Analysis
  11.2. Viral Clearance Distributors and Customers
  11.3. Viral Clearance Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Lonza Group
     11.4.2. Charles River Laboratories International, Inc.
     11.4.3. Sigma-Aldrich Corporation
     11.4.4. Merck KGaA
     11.4.5. Avance Biosciences Inc.
     11.4.6. Clean Cells
     11.4.7. BSL Bioservice Scientific Laboratories GmbH

Segments Covered in the Report
The global viral clearance market has been segmented on the basis of
Applications

  • Cellular & Gene Therapy Products
  • Blood & Blood Products
  • Vaccines & Therapeutics
  • Tissue & Tissue Products
  • Stem Cell Products

Methods

  • Viral Inactivation Method
  • Viral Detection Method
  • Viral Removal Method

End-users

  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

 

Key players competing in the global viral clearance market are Lonza Group; Charles River Laboratories International, Inc.; Sigma-Aldrich Corporation; Merck KGaA; Avance Biosciences Inc.; Clean Cells; BSL Bioservice Scientific Laboratories GmbH; SGS S.A.; Texcell, Inc.; and Wuxi PharmaTech Inc. The main market players are continuously looking for several market development activities and opportunities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations to enhance their market positions.

Global Viral Clearance Market keyplayers

Buy Report